Harmonic Discovery

Harmonic Discovery

Edit info

  • Founded: 2021
  • Location: New York, NY
  • Employee range: 1 - 10
  • Clinical stage: RD
  • Therapy area: AML
  • Drug types: ONC
  • Lead product: Undisclosed
  • Funding: $8M seed Sep 2022
  • Investors: Innovation endeavors, Fifty Years, Y Combinator, Boom Capital, Caffeinated Capital


harmonicdiscovery.com

linkedin.com

job board


Business:

Kinome-targeting Therapies

Drug notes:

3 additional undisclosed programs RD myelofibrosis, oncology, undisclosed

About:

Harmonic Discovery is developing new therapeutic drugs that embrace the complexity of diseases. The current paradigm of drug discovery involves identifying drugs that target a single biological mechanism. Harmonic on the other hand are creating a new generation of therapeutics that can disrupt multiple pathways by targeting the human kinome. The kinome includes a family of 500 proteins associated with diseases such as cancer, autoimmunity and neurodegeneration. To find therapeutics, Harmonic is using their platform that integrates multiple layers of information from 3D-protein structure to systemic changes in protein gene expression using medicinal chemistry and machine learning.

Post a job


© 2025 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com